-
Join 357 other subscribers
Blogroll
HIV/AIDS networks
Links
- bilaterals.org
- Fix the Patent Laws!
- FTA Malaysia
- HAI Europe
- Health Action International (HAI)
- Intellectual Property Watch
- Lawyers Collective HIV/AIDS
- MSF Access Campaign
- Patent Opposition Database
- Public Citizen
- Stop EU-India FTA
- Stop Peru FTA
- Third World Network
- Treatment Action Group
- UAEM Europe
- UAEM evidence collection
- Universities Allied for Essential Medicines (UAEM)
Archives
-
Recent Posts
- Clamour against United Kingdom’s free-trade negotiator
- India, EU conclude another round of talks for proposed trade agreement
- Next round of India, UK talks for free trade agreement to be held in March
- ‘Playing with the lives of HIV patients’: Drug shortages force many to change medication regime
- Pfizer’s Covid pill Paxlovid gets WHO’s approval. All you need to know
Categories
Tag Archives: Hoffmann-La Roche
ITALIAN COMPETITION AUTHORITY OPENS PROCEEDINGS AGAINST ROCHE GROUP AND NOVARTIS GROUP
Autorità Garante della Concorrenza e del Mercato DIREZIONE CENTRALE RELAZIONI ESTERNE UFFICIO STAMPA Source: AGCM PRESS RELEASE ANTITRUST: ITALIAN COMPETITION AUTHORITY OPENS PROCEEDINGS AGAINST ROCHE GROUP AND NOVARTIS GROUP FOR AN ALLEGED CARTEL RELATED TO THE SALES IN ITALY OF THE PHARMACEUTICAL PRODUCTS … Continue reading
Posted in Anti competition
Tagged Bevacizumab, European Union, Genentech, Hoffmann-La Roche, Italy, Lucentis, Novartis
Leave a comment
India: Balancing Public And Private Interests In The Intellectual Property Regime
Published on 18 September 2012 @ 2:03 pm By Patralekha Chatterjee for Intellectual Property Watch NEW DELHI – In this month, there have been two court orders in India that underscore the complexities underlying the country’s intellectual property regime. … Continue reading
Don't trade our lives away 